Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04972435
Other study ID # Naris001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2, 2014
Est. completion date December 30, 2015

Study information

Verified date July 2021
Source Siriraj Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This prospective study included patients with primary angle-closure (PAC or primary angle-closure glaucoma (PACG) and visually significant cataract. Phacoemulsification with multifocal intraocular lens (MIOL) or monofocal IOL (mIOL) (patient preference) was performed. Collected data included best-corrected distant visual acuity (BCVA), intraocular pressure (IOP), anterior chamber depth (ACD), and contrast sensitivity (CS) measured at spatial frequency 1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree (CPD) preoperatively, and at 2-6 months postoperatively. Preoperative and postoperative parameters were compared to evaluate the effect of MIOL on CS in eyes with PAC or PACG.


Description:

This prospective non-randomized clinical study was conducted at the Department of Ophthalmology of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand during January 2014 to December 2015. The study protocol and informed consent procedures were both approved by our center's institutional review board (IRB) (approval number Si 384/2014). Each patient provided written informed consent prior to participation. Primary angle closure was defined as an eye with invisible non-pigmented trabecular meshwork greater than 180 degrees and evidence of peripheral anterior synechiae on gonioscopy without glaucomatous optic disc appearance, glaucomatous pattern visual field damage, or history of increased IOP. Primary angle closure glaucoma was defined as an eye with invisible non-pigmented trabecular meshwork greater than 180 degrees on gonioscopy with glaucomatous optic damage (cup-to-disc ratio greater than 0.5 and/or localized neuro-retinal rim defect) and history of increased IOP raising. Patients with PACG must have been under good disease control, which was defined as IOP under 20 mmHg with 1 to 3 topical anti-glaucoma medications without deterioration of visual field, except generalized depression from cataract. Intra-ocular lens calculation was performed at the baseline visit using IOL Master. All patients received information about the advantages and disadvantages of MIOLs (Tecnis ZMB00 or Acrysof IQ Restore SN6AD1) and of mIOLs (Tecnis ZCB00 or Acrysof IQ SN60WF) before choosing the type of IOL that they individually preferred. Cataract surgery was performed by a single surgeon. Topical anesthesia was applied before standard phacoemulsification (2.2 mm temporal clear cornea incision and continuous curvilinear capsulorhexis) and IOL implantation into the capsular bag. Eyes with any intraoperative or postoperative complication were excluded. Data specific to uncorrected and best-corrected distant visual acuities (UCVA and BCVA) in logMar, auto-refraction, slit-lamp ophthalmoscopic examination, intraocular pressure (IOP) measurement with Goldmann applanation tonometry, contrast sensitivity (CS), anterior chamber depth (ACD), central corneal thickness (CCT), and axial length (AL) were collected on the preoperative screening day, and at the 2 to 6-month postoperative follow-up. CS was measured under normal room light (photopic) conditions to evaluate patient quality of vision during the performance of their daily activities using a Functional Vision Analyzer. This test produces sine-wave gratings of different spatial frequencies. The absolute values of distance CS were obtained at five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree; CPD). VisanteĀ® AS-OCT was used to determine CCT and ACD. ACD was defined as the distance between the corneal endothelium and the anterior surface of the crystalline lens (preoperative) or iris plane (postoperative). Axial length was obtained using IOL Master. Comparisons of continuous data with normal distribution were made using Student's t-test for unpaired data, and using Mann-Whitney U test for non-normally distributed data. A p-value of less than 0.05 was defined as denoting statistical significance.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date December 30, 2015
Est. primary completion date December 30, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Visually significant cataract patients aged >18 years with PAC or PACG who underwent prophylaxis peripheral iridotomy at least 2 months prior to participation. Exclusion Criteria: - Patients with preexisting glaucomatous visual field defect, except generalized depression - Any other concurrent ocular diseases that could affect visual acuity, except cataract - History of ocular inflammation or ocular surgery, except laser peripheral iridotomy, which is a routine procedure for treating PAC/PACG

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Contrast sensitivity
All subjects performed the contrast sensitivity measurement preoperatively and one time at 2 months postoperatively.

Locations

Country Name City State
Thailand Naris Kitnarong Bangkoknoi Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Siriraj Hospital

Country where clinical trial is conducted

Thailand, 

References & Publications (4)

Kim CY, Chung SH, Kim TI, Cho YJ, Yoon G, Seo KY. Comparison of higher-order aberration and contrast sensitivity in monofocal and multifocal intraocular lenses. Yonsei Med J. 2007 Aug 31;48(4):627-33. — View Citation

Kumar BV, Phillips RP, Prasad S. Multifocal intraocular lenses in the setting of glaucoma. Curr Opin Ophthalmol. 2007 Feb;18(1):62-6. Review. — View Citation

Montés-Micó R, Alió JL. Distance and near contrast sensitivity function after multifocal intraocular lens implantation. J Cataract Refract Surg. 2003 Apr;29(4):703-11. — View Citation

Teichman JC, Ahmed II. Intraocular lens choices for patients with glaucoma. Curr Opin Ophthalmol. 2010 Mar;21(2):135-43. doi: 10.1097/ICU.0b013e3283365154. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Contrast sensitivity Contrast sensitivity at partial frequency 1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree (CPD) Preoperative (on screening day)
Primary Contrast sensitivity Contrast sensitivity at partial frequency 1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree (CPD) At 2nd month postoperatively
Secondary Visual acuity Visual acuity at distance in LogMar Preoperative (on screening day)
Secondary Visual acuity Visual acuity at distance in LogMar At 2nd month postoperatively
Secondary Anterior chamber depth Anterior chamber depth Preoperative (on screening day)
Secondary Anterior chamber depth Anterior chamber depth At 2nd month postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT04468308 - VRQOL in Cataract Patients During the COVID-19 Pandemic
Completed NCT06192901 - Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery
Completed NCT06383754 - Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study N/A
Completed NCT03262285 - Corneal Endothelial Cell Loss After Phacoemulsification Compared With Extracapsular Cataract Extraction
Recruiting NCT05646004 - 621 Real World Study N/A
Active, not recruiting NCT02966496 - Safety and Efficacy of Implantation of Two Multifocal Intraocular Lenses in the Treatment of Senile Cataract N/A
Completed NCT03050008 - Efficacy of FLACS USFREE Compared to Traditional Surgery Using Ultrasound. N/A
Completed NCT05014269 - Phacoemulsification in Patients With Corneal Opacities
Not yet recruiting NCT03766230 - Clinical Study on Second-eye Pain in Cataract Surgery